Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Specialists recommend that people with type 2 diabetes test their hemoglobin A1C levels at least once every six months if they have stable blood sugar levels in a healthy range. If your blood sugar ...

Are you in the gray zone? Millions are living with prediabetes, unaware of the crucial difference between it and full-blown type 2 diabetes. Let’s ...

China: A study published in the journal Endocrine found that blood glucose fluctuations are significantly linked to the risk ...

An adult with suspected type 2 diabetes starts treatment with semaglutide, but his A1c keeps getting worse. Medscape Family Medicine, March 10, 2025 Are Smartphone Alerts Reliable for Diabetes ...

Testing your blood sugar gives you important information about how well your type 2 diabetes management and treatment plan is working. It lets you see how factors such as food, exercise ...

Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist, significantly reduced hemoglobin A1c (HbA1c) in adults with type 2 diabetes (T2D) and inadequate glycemic control with diet ...

A daily pill from Eli Lilly lowered blood sugar levels and induced weight loss in people with Type 2 diabetes, the company ...

There is no cure for diabetes. The warning signs of diabetes can be so mild that you don't notice them. That's especially true of type 2 diabetes. You cannot treat diabetes on your own.

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

A screening initiative in West Chicago found that 50% of food-insecure individuals had abnormal A1c levels, with many unaware ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.